Afya (NASDAQ:AFYA) Stock, Quote.Headers.trade-ideas

Afya

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Earnings

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

AFYA

Adtalem Global Education Inc. Common Stock

ATGE

Afya Limited (NASDAQ: AFYA) completed the acquisition of the total share capital of Unidom Participacoes S.A. (Unidompedro and Faculdade Dom Luiz) through its wholly-owned subsidiary Afya Participacoes S.A.

AFYA Welcomes 300 Operational Medical School Seats in Salvador

Price Target

CRWD

CTVA

GEHC

ODFL

SCCO

SNPS

TEVA

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday

Equities

Guidance

General

Brazil&#39;s Afya Posts 23% Revenue Growth In Q2 Aided By Higher Tickets In Medicine Courses

Afya Ltd

WIIM

3D Systems shares are trading higher after the company announced it received FDA clearance for its monolithic jetted denture solution.

TDOC

Teladoc Health shares are trading higher after Jefferies raised its price target on the stock from $8 to $10.

Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) has outperformed the market over the past 5 years by 3.68% on an annualized basis producing an average annual return of 17.29%. Currently, Nutanix has a market capitalization of $14.71 billion. 
Buying $100 In NTNX: If an investor had bought $100 of NTNX stock 5 years ago, it would be worth $224.75 today based on a price of $59.66 for NTNX at the time of writing.
<h3>Nutanix's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726590794_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTNX

Here's How Much You Would Have Made Owning Nutanix Stock In The Last 5 Years

Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) <a href="https://www.globenewswire.com/news-release/2024/09/16/2947020/0/en/Clearmind-Medicine-Announces-the-Notice-of-an-International-Patent-Application-for-Pioneering-Ibogaine-Combination-Therapy.html">filed</a> a patent application for its combination therapy involving <a href="https://www.benzinga.com/topic/ibogaine">Ibogaine and N-Acylethanolamines</a>. 
What Happened: The therapy was developed in <a href="https://www.benzinga.com/markets/cannabis/22/08/28621569/psychedelic-based-cocaine-addiction-treatment-under-study-is-showing-positive-results-this-is-wh">collaboration</a> with SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>). It combines the psychedelic compound Ibogaine with Palmitoylethanolamide (PEA), which is a member of the N-Acylethanolamines family. It aims to improve the safety and efficacy of Ibogaine-based treatments. 
Ibogaine, derived from the African shrub <a href="https://www.benzinga.com/markets/cannabis/22/04/25315203/what-is-iboga-and-how-does-it-compare-to-cannabis-exactly">Tabernanthe iboga</a>, has already <a href="https://www.benzinga.com/markets/cannabis/23/05/32452579/african-iboga-root-heads-to-canadian-company-developing-natural-drugs-to-help-treat-addictions">shown potential</a> in addressing opioid, cocaine, and other substance use disorders.
See Also: <a href="https://www.benzinga.com/general/biotech/24/02/37412608/gh-research-this-european-biotech-company-reports-full-year-2023-financial-results-and-business-u" target="_blank" rel="noreferrer noopener">GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates</a>
Why It Matters: The patent signifies a significant advancement in treating mental health and substance use disorders.
Ibogaine has also garnered attention in clinical trials for its effectiveness in combating addiction. However, its use has not been without controversy. There are reports of adverse effects or fatalities related to the ingestion of iboga or Ibogaine. 
Clearmind Medicine&#8217;s combination seeks to mitigate these risks while enhancing the therapeutic benefits of the treatment.
"The publication of this patent highlights Clearmind's commitment to leadership in the <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psychedelics space</a> through building a diverse patent portfolio, featuring technologies with varying timelines to market,&#8221; Clearmind Medicine CEO Adi Zuloff-Shani said. &#8220;Most importantly, we aim to provide safe and effective solutions for mental health conditions that currently have unmet needs."
SciSparc specializes in treatments targeting central nervous system disorders. The company has been exploring <a href="https://www.benzinga.com/general/biotech/24/08/40437653/israeli-penny-stock-biotech-scisparc-outlicenses-its-cannabinoid-pain-therapy">cannabinoid-based therapeutics</a>, which complement Clearmind&#8217;s work in psychedelic research.
SciSparc&#8217;s experience in clinical-stage pharmaceuticals provides critical expertise in advancing the therapy.
Together, Clearmind and SciSparc are working on expanding the scope of their research to address various mental health issues, particularly focusing on safe and effective solutions for addiction.
Clearmind Medicine&#8217;s intellectual property portfolio currently comprises of 19 patent families and 29 granted patents.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40730912/irish-biotech-firm-gh-research-sees-cash-decline-in-q2-advances-psychedelic-drug-trials">Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials</a></li>
</ul>
Cover image made with AI

Cannabis

Psychedelics

Health Care

Press Releases

CMND

SPRC

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

Live On CNBC, Stephanie Link Announces Bought More Chipotle Mexican Grill, Bought Exxon Mobil

Plains All American's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NYSE">PAA</a>) short percent of float has risen 5.99% since its last report. The company recently reported that it has 10.65 million shares sold short, which is 2.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Plains All American Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726590622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Plains All American has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Plains All American's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Plains All American's peer group average for short interest as a percentage of float is 4.20%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Plains All American?

JMP Securities analyst Trevor Walsh reiterates Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) with a Market Perform.

Reiteration

PIPR

JMP Securities Reiterates Market Perform on Piper Sandler

Home Depot's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) short percent of float has risen 9.38% since its last report. The company recently reported that it has 10.44 million shares sold short, which is 1.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Home Depot Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726590617_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Home Depot has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Home Depot's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Home Depot's peer group average for short interest as a percentage of float is 6.16%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Home Depot's Recent Short Interest

Albemarle's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has fallen 3.68% since its last report. The company recently reported that it has 11.86 million shares sold short, which is 11.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726590611_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Albemarle has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 3.04%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Albemarle's Recent Short Interest

BofA Securities analyst Justin Post maintained a Buy rating on Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a price target of $210.
The re-rating reflects CEO Andy Jassy&#8217;s <a target="_blank" href="https://www.benzinga.com/top-stories/24/09/40887347/amazon-to-cut-management-layers-end-work-from-home" rel="noreferrer noopener">goal for a leaner</a> Amazon by the end of the first quarter of 2025, translating into an estimated $700 million in cost savings and Amazon Web Services&#8217; multi-year, <a target="_blank" href="https://www.benzinga.com/news/24/09/40897994/whats-going-on-with-intel-stock-on-tuesday" rel="noreferrer noopener">multi-billion-dollar</a> co-investment into custom AI chips with Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>).
Post noted that Intel chips would be more cost-effective for customers than alternatives. Intel will produce custom AI fabric chips for AWS that will be built on Intel 18A, the company&#8217;s most advanced process node.
According to the analyst, AWS remains well-positioned to capture broad-based AI customer demand due to its more diverse and growing product offering.
Post estimates $700 million annually in cost savings under Jassy&#8217;s plans to increase Amazon&#8217;s individual contributor-to-manager ratio by slashing management layers&nbsp;and making employees return to the office five days a week beginning in January.
Assuming a non-warehouse workforce of 400,000 and a current manager-to-contributor ratio of 1 to 6, at least 2.5% of employees (around 7,000) are projected to shift from manager roles to contributor positions, and if the difference in pay is $100,000.
Post&#8217;s price target is based on his sum-of-the-parts (SOTP) analysis, which values the 1P retail business at 1.2 times 2025E Revenue, the 3P retail business at 3.0 times 2025E Revenue, AWS at 8.0 times 2025 Sales, and the advertising business at 5.0 times 2025 Sales.
For 2025E, Post&#8217;s 8.0 times AWS multiple is relatively below his SaaS comps at 8.5 times, his 1.2 times GMV multiple is a discount to his retail comps at 1.3 times, and his 5.0 times advertising multiple is a discount to his digital advertising comps at 5.2 times.
The analyst deems some conglomerate discounts as warranted with elevated regulatory risk but long-term notes that in-line to discount multiples are warranted given growth rates more than peers.
Price Action: AMZN stock is up 1.22% at $187.15 at the last check on Tuesday.
Image via Shutterstock

Analyst Color

Tech

AMZN

INTC

Amazon's Leaner Structure and AI Chip Partnership with Intel Could Boost Growth: BofA Analyst

The state of California will always play an important role in the history of Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) even after the electric vehicle giant moved its headquarters to <a href="https://www.benzinga.com/news/22/06/27744152/california-is-gerrymandered-for-democratic-outcome-says-elon-musk-how-politics-played-into-teslas-mo">Texas in 2021.</a>
Tesla is set to pay tribute to the state of California with a new statue.
What Happened: The <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/11/36032944/cybertruck-delivery-event-elon-musk-highlights-teslas-best-product-says-finally-the">design of the Cybertruck</a> has been met with praise and also drawn plenty of criticism for its unique structure and how it differs from traditional pickup trucks.
Those who don't like the design of the Cybertruck may not love hearing about a new statue in the state of California.
"Tesla's latest invention looks like what would happen if the California flag could mate with a Cybertruck. It's a grizzly bear, made of meta polygons, illuminated by spotlights," Palo Alto Online <a href="https://www.paloaltoonline.com/technology/2024/09/16/tesla-plans-a-grizzly-display-on-page-mill-road/">writes</a>.
The proposed statue would be present on Page Mill Road in Stanford Research Park, near Tesla's engineering headquarters.
"The concept is a stylized, low-poly California Grizzly bear meant to combine Tesla's design language with California's Grizzly bear, and highlight the common message of strength and unyielding resistance," the statue application reads.
The filing says the bear would be 16 feet and 5 inches long and 11 feet and 5 inches tall. The bear will be made of aged metal according to the filing, which would represent Tesla's "roots in the industry" and also show a "sense of strength, durability, and precision manufacturing."
Tesla also plans on having glowing spotlights around the bear statue that can provide different colors and lighting designs based on events and holidays.
The grizzly bear is the official state animal of California and featured prominently on the state&#8217;s flag. 
The statue is located where an HP Enterprises monument sign once stood, as the company was the former tenant of the building that Tesla has called its engineering headquarters since 2023.
Tesla's statue plans are being reviewed by the city's Department of Planning and Development Services, according to the report.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent091724">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: Tesla was founded in California in 2003 and called the state home for many years before moving its headquarters to Texas in 2021.
Musk has also moved several other businesses out of California, announcing in July that his SpaceX and X would <a href="https://www.benzinga.com/news/24/07/39804744/spacex-x-to-move-headquarters-from-california-to-texas-musk-calls-it-the-final-straw-criticizes-gov">move their headquarters</a> to Texas.
California remains home to Tesla&#8217;s engineering headquarters, where the bear statue will be located, as well as the Fremont factory, the largest automotive production facility in the United States.
Building the statue in California could symbolize that Tesla will have at least a partial home in the state for the foreseeable future despite CEO Elon Musk vocally opposing several state policies and the politics of the state's government.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39918390/tesla-q2-earnings-highlights-revenue-beat-eps-miss-robotaxi-update-2024-growth-rate-to-be-notably-l">Tesla Q2 Earnings Highlights: Revenue Beat, EPS Miss, Robotaxi Update, 2024 Growth Rate To Be &#8216;Notably Lower&#8217; Than 2023</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

TSLA

Elon Musk, Tesla May Have Soured On California, But They're Showing Love With A Cybertruck-Inspired Statue

DCOM

Dime Community Bancshares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $29 to $35.

ORCL

Live On CNBC, Bill Baruch Announces Sold Oracle

Definitive Healthcare shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a price target of $7.

DA Davidson analyst Michael Shlisky maintains Timken (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKR#NYSE">TKR</a>) with a Buy and maintains $103 price target.

DA Davidson Maintains Buy on Timken, Maintains $103 Price Target

FTEL

Fitell Shares Resume Trade, Then Halt Again On Circuit Breaker To The Downside, Stock Now Down -49.2%

SNBR

Sleep Number shares are trading higher after Piper Sandler raised its price target on the stock from $12 to $16.

JMP Securities analyst Reni Benjamin reiterates Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) with a Market Perform.

INCY

JMP Securities Reiterates Market Perform on Incyte

If a market is trending lower, it is out of equilibrium. There aren't enough buy orders to absorb all of the sell orders. Because of this, sellers need to offer their shares at a discount to get buyers interested. This forces the stock into a downtrend.
At a support level, there is enough demand — buy orders — to absorb all of the supply — sell orders. This is why sell-offs end or pause when they reach them. 
If the price eventually moves below the support, traders say the support was broken. As you can see on the chart, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) may be breaking support around the $218 level. This is why it's our Stock of the Day.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17121124/1-15-1024x626.png" alt="" class="wp-image-552271" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17121124/1-15-1024x626.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17121124/1-15-300x184.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17121124/1-15-768x470.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17121124/1-15.png 1182w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This move could be related to the<a href="http://iPhone 16 Pro Demand Lags, Longer Wait Times Globally, China Shows Smaller Gap: Analyst"> lower-than-expected demand for the iPhone16.</a>
When support &#8220;breaks&#8221; a new downtrend may form. If the price is below the support level, it illustrates an important supply and demand dynamic.  It means investors and traders who created the support with their buy orders are gone.
They have canceled or finished their orders. Either way, they have left the market. This could set the stage for a move lower.
With buyers out of the way, sellers have difficulty finding someone to sell their shares. The market is out of equilibrium. As a result, to get buyers interested, the sellers need to push the price lower. This results in a new downtrend forming.
Read Also: <a href="https://www.benzinga.com/news/econ-s/24/09/40902634/retail-spending-remains-on-solid-footing-but-fed-must-weigh-rate-cuts-impact-on-workers-says-economi">iPhone 16 Pro Demand Lags, Longer Wait Times Globally, China Shows Smaller Gap: Analyst</a>
There is a reason why there was support for Apple around $218. In the stock market, some price levels are more important than others. And the $218 level has been important for Apple since June.
It was a resistance level and then it converted into a support level. Resistance can turn into support because of seller's remorse.
There are traders and investors who regret their decision to sell when the stock is at resistance if the price eventually moves higher.  Some of them decide to buy their shares back if they can get them for the same price they were sold.
So, when the price eventually falls back to the level that is previously resistance, they place buy orders. If there are enough of them, it forms support at the price that was resistance.
Holders of <a href="https://www.benzinga.com/quote/AAPL">Apple</a> need to be cautious. Now that this support appears to be broken, the stock may be headed lower.
Read Next: • <a href="https://www.benzinga.com/markets/equities/24/09/40895240/wall-street-could-head-higher-as-traders-look-forward-to-retail-sales-data-ahead-of-fed-decision">Wall Street Could Head Higher As Traders Look Forward To Retail Sales Data Ahead Of Fed Decision, Tech Stocks On The Mend: Strategist Flags This As Best-Case Scenario For Market This Week</a>

Photo: Shutterstock

Technicals

AAPL

Stock Of The Day: Will Apple Bring The Market Down?

RCKT

Rocket Pharmaceuticals shares are trading higher after the company announced that all patients have bene enrolled in the global Phase 2 clinical trial evaluating RP-A501 to treat male patients with Danon Disease.

Afya Limited (AFYA) Q2 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Syndax Pharmaceuticals (SNDX – Research Report), Afy...

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Afya (AFYA) and LENZ Therapeutics (LENZ)

Analyst Mauricio Cepeda of Morgan Stanley maintained a Hold rating on Afya (AFYA – Research Report), reducing the price target to $18.00. Mauricio ...

Hold Rating on Afya Amid Strong Performance and Future Risks

Afya GAAP EPS of R$1.74, revenue of R$809.89M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Afya (NASDAQ:<a href="https://investorplace.com/stock-quotes/afya-stock-quote/">AFYA</a>) just reported results for the second quarter of 2024.<ul><li>Afya reported earnings per share of 44 cents. This was above the analyst estimate for EPS of 35 cents.</li><li>The company reported revenue of $155.43 million.</li><li>This was 5.45% better than the analyst estimate for revenue of $147.40 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/afya-stock-earnings-afya-for-q2-of-2024/">AFYA Stock Earnings: Afya Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AFYA Stock Earnings: Afya Beats EPS, Beats Revenue for Q2 2024

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Afya (AFYA) has released an update. Afya Limited, a premier medical education group in Brazil, has secured a full disbursement of R$500 million fro...

Afya Receives R$500 Million Boost for Expansion

Afya secures BRL 500M loan from IFC

Afya announces MEC decision on medical seats reconsideration

Afya (AFYA) has released an update. Afya Limited, a leading medical education group in Brazil, has successfully reinstated 10 medical seats at Unig...

Afya Limited Expands Medical Seats in Brazil

LENZ

SNDX

Afya Limited (the "Company") Notice of Annual General Meeting of the Company

Afya Limited Announces Results of Annual General Meeting Held on June 5, 2024

Afya Announces Changes to Its Board of Directors

Afya Limited Announces Closing of the Acquisition of Unidompedro and Faculdade Dom Luiz

Afya Limited Announces Medical Seats Increase in UNIMA Alagoas

Afya Limited Releases 2023 Sustainability Report

Afya Secures Loan of up to R$500 Million From IFC to Support the Company's Expansion

Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results

Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion

Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio

American Public Education, Inc. - Common Stock

American Public Education

Adtalem Glb Education

Bright Horizons Family Solutions Inc. Common Stock

Bright Horizons Family

Chegg

51Talk Online Education Group American depositary shares, each representing 60 Class A ordinary shares

51 Talk Online Education

Coursera

Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share

Youdao

Duolingo

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 10 Ordinary Share (Cayman Islands)

New Oriental Education

Graham Hldgs

Gaotu Techedu Inc. American Depositary Shares

Gaotu Techedu

Laureate Education

Lincoln Educational Services Corporation - Common Stock

Lincoln Educational Servs

Grand Canyon Education, Inc. - Common Stock

Grand Canyon Education

Stride

Nerdy

Perdoceo Education Corporation - Common Stock

Perdoceo Education

Pearson

QuantaSing Group Limited - American Depositary Shares

QuantaSing Group

Sunlands Technology Group American Depositary Shares, representing Class A ordinary shares

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Afya

Afya (AFYA) Forecast

Afya (NASDAQ:AFYA) Stock, Quote.Headers.trade-ideas